UWorld Pharmacology Practice Test

The statement regarding the timing of the ischemic stroke in relation to a recent surgery raises the need for clarification. Patients receiving tissue plasminogen activator (tPA) for an ischemic stroke must be evaluated carefully regarding their medical history and the timing of other surgical procedures due to specific contraindications associated with tPA use.

In this case, if the client has undergone stomach surgery very recently, it may increase the risk of complications like bleeding, especially since tPA is an anticoagulant and can exacerbate the risk of hemorrhagic events. It is crucial to gather more information about the type and extent of the surgery, as well as the time frame, to assess whether the medication can be safely administered.

The other statements do not raise similar concerns related to the use of tPA. Previous concussions and the discontinuation of warfarin carry less immediate risk concerning the administration of tPA compared to recent surgeries, making the latter statement particularly relevant for further discussion and clarification. Additionally, the timeline of symptom onset related to the patient's arm weakness is critical for determining treatment protocols, but does not indicate a need for clarification regarding safety.